Bright Spots in Healthcare

The episode contains several genuinely useful operational insights - the ROI mismatch for low-risk vs. high-risk hypertension populations, the 'pilot mode trap' that prevents hitting scale, and the technology-amplifies-dysfunction principle - but these are diluted by repetition, meandering dialogue, and some high-level strategic observations that don't resolve into actionable specifics.

“when you bring in technology, it amplifies like what's already there. So if you don't have a care model, it's going to amplify dysfunction and discordination”

“if you define the specific high risk population that ends up in the hospital a lot, that's probably true. Advanced heart failure for example. But when you look at that population being low risk, stage one, even stage two hypertension, that's probably not going to be the roi”

There is genuine first-hand contrarian thinking - particularly that chronic condition ROI cannot be built on hospitalization reduction for low-risk populations, and that piloting at small scale is itself the failure mode - but the framing stays within familiar population health territory and most frameworks are drawn from lived experience rather than novel conceptual models.

“if you sit in that pilot mode for six months or a year, that's what a lot of people do, then you're never going to hit the numbers and that pilot failed because you got stuck in almost the preview”

“Don't expect to sell the ROI being that you're going to reduce readmissions and admissions for blood pressure alone. But maybe what it is is that we bill better and we get a high enough volume so that we're able to capture the billing”

Dr. Gupta is a genuine senior practitioner - Chief of Population Health at a major academic medical center - who has personally overseen a failed pilot, diagnosed the causes, rebuilt the program, and generated measurable outcomes, making her directly relevant and credible rather than a career thought-leader.

“we actually interviewed, uh, uh, probably like 20 places when we were kind of revamped. We were given the initial pilot and it was like, this is broken. And before we cancel the program, can we try something”

“patients that kind of enroll and are in this program complete the program by six months. We're averaging blood pressures that were above goal around 146 over 81 and by six months getting them into goal range which is less than 130 over 80 um, with an average about 126 over 73”

The episode includes concrete figures - blood pressure outcomes (146/81 to 126/73), patient volumes (~150k primary care, ~400 RPM targets), program duration (6 vs. 12 months), and specific workflow failures (vendor RN unable to schedule in EHR) - giving practitioners real reference points, though financial figures and unit economics remain largely qualitative.

“we have about 100 primary care physicians that see, um, about 150,000 patients in primary care”

“We were targeting initially for phase one blood pressures that were above 140 over 90”

The host surfaces genuinely useful follow-up threads - probing the workflow-to-contract sequencing failure and vendor accountability - but repeatedly dilutes quality with self-referential framing, the forced 'Gupta pilot process' naming, forgetting his own question mid-episode, and a Walmart anecdote that substitutes analogy for direct interrogation.

“I'm going to put a pin in that”

“I already forgot it. So we talk. Oh, cardio, metabolic and the complexities. God, I can't remember it now”